^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BAL0891

    i
    Other names: BAL0891, BAL-0891, BAL 0891, TTK-CS-101
    Associations
    News
    Trials
    Company:
    Basilea, Crossfire Oncology, SillaJen
    Drug class:
    PLK1 inhibitor, TTK inhibitor
    Related drugs:
    Associations
    News
    Trials